22 March 2019

NHS waiting times for elective and cancer treatment

NHS waiting times for elective and cancer treatment
NAO 22 March 2019
  • This review presents data on the NHS’s performance against current waiting times standards for elective and cancer care in England, and some of the factors associated with that performance.
  • " It is hard to see how the NHS will be able to recover its position on waiting times in the near future without significant investment in staffing and infrastructure."
Report conclusions

17 March 2019

Cancer services profiles

Cancer services profiles
PHE updated March 2019
  • This tool contains data on cancer services at GP and CCG level collated by the National Cancer Registration and Analysis Service (NCRAS). It replaces the GP Cancer Profiles that were previously contained within the Cancer Commissioning Toolkit.
  • Includes data on cancer incidence and screening, diagnostic services, Two Week Wait referrals, emergency presentations and admissions.

15 March 2019

Population screening: access for people with severe mental illness

Population screening: access for people with severe mental illness
PHE 15 March 2019
  • Information for commissioners and screening providers, to help improve access to screening for people with severe mental illness.
  • Appendix 1 is a list of mental health service providers across England.

11 March 2019

Clinical review of NHS access standards interim report

Clinical review of NHS access standards interim report
NHS England 11 March 2019
  • In 2018 Professor Stephen Powis, NHS National Medical Director, was asked to carry out a clinical review of standards across the NHS, with the aim of determining whether patients would be well served by updating and supplementing some of the older targets currently in use. In this interim report, Professor Powis sets out his recommendations for doing so in mental health, cancer, urgent and emergency care, and elective care.
  • For background see: Clinical review of NHS access standards

7 March 2019

Cochlear implants for children and adults with severe to profound deafness - assessing benefits

Cochlear implants for children and adults with severe to profound deafness [TA566]
NICE Technology appraisal guidance 7 March 2019
  • This guidance has been updated after a review of the criteria for defining severe to profound deafness and for assessing adequate benefit from acoustic hearing aids. No other sections of the guidance have been updated, so these are the same as in the original guidance. 
  • Commissioners have 3 months from publication to implement these recommendations.
  • "Currently around 1,260 people in England receive cochlear implants each year. These updated recommendations could lead to a 70% increase in that number, to 2,150 people, once a steady state is reached in 2024/25" - from NICE news item discussing the impact of the change, including costs.

1 March 2019

Improving Complex Pediatric and Adult Spine Care While Embracing the Value Equation.

Improving Complex Pediatric and Adult Spine Care While Embracing the Value Equation. [PubMed]
Spine Deform. March 2019 ;7(2):228-235. doi: 10.1016/j.jspd.2018.08.006.
  • This paper summarises various methods by which value can be increased in complex spine surgery, both through the improvement of outcomes and the reduction of cost. These methods centre around standardisation, team-based and collaborative approaches, rigorous outcomes tracking through dashboards and registries, and continuous process improvement.

Abstract